scholarly article | Q13442814 |
P356 | DOI | 10.1002/HON.888 |
P8608 | Fatcat ID | release_frzokepk5jheziiysne7jsayam |
P698 | PubMed publication ID | 19247978 |
P50 | author | Massimo Gentile | Q88195209 |
Fortunato Morabito | Q90396313 | ||
Sonia Fabris | Q39052038 | ||
Luca Baldini | Q39052059 | ||
Stefano Molica | Q59660152 | ||
P2093 | author name string | Andrea Ferrario | |
Francesca Rossi | |||
Antonino Neri | |||
Manlio Ferrarini | |||
Giovanna Cutrona | |||
Marta Lionetti | |||
Lilla Cro | |||
Nadia Zucal | |||
P2860 | cites work | Diagnostic role and prognostic significance of a simplified immunophenotypic classification of mature B cell chronic lymphoid leukemias | Q78800345 |
Zeta-chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia | Q81324241 | ||
Genomic aberrations and survival in chronic lymphocytic leukemia | Q28141442 | ||
CD26/dipeptidyl peptidase IV in context. The different roles of a multifunctional ectoenzyme in malignant transformation | Q33701851 | ||
CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. | Q33956997 | ||
CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes. | Q34368489 | ||
CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia. | Q34521017 | ||
Guidelines on the diagnosis and management of chronic lymphocytic leukaemia | Q35746607 | ||
Constitutive expression of CD26/dipeptidylpeptidase IV on peripheral blood B lymphocytes of patients with B chronic lymphocytic leukaemia. | Q36617545 | ||
The CD38 ectoenzyme family: advances in basic science and clinical practice | Q36767533 | ||
The cytoplasmic tail of the T cell receptor zeta chain is required for signaling via CD26. | Q39255555 | ||
Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. | Q39809953 | ||
Skin homing of Sézary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/dipeptidylpeptidase IV. | Q40365618 | ||
Regulation of p38 phosphorylation and topoisomerase IIalpha expression in the B-cell lymphoma line Jiyoye by CD26/dipeptidyl peptidase IV is associated with enhanced in vitro and in vivo sensitivity to doxorubicin | Q40440044 | ||
Functional role of CD26 on human B lymphocytes | Q41377278 | ||
CD26/dipeptidyl peptidase IV expression in human lymphomas is restricted to CD30-positive anaplastic large cell and a subset of T-cell non-Hodgkin's lymphomas | Q41413255 | ||
Clinical significance of CD38 expression in chronic lymphocytic leukemia | Q43775864 | ||
Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells | Q44241973 | ||
Constitutive activation of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase in B-cell lymphoproliferative disorders | Q44458721 | ||
Association of CD26 with CD45RA outside lipid rafts attenuates cord blood T-cell activation | Q44606441 | ||
World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. | Q46038765 | ||
Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia. | Q53864608 | ||
ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. | Q55036524 | ||
CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells | Q57374952 | ||
Regulation of CD26/DPPIV gene expression by interferons and retinoic acid in tumor B cells | Q57662605 | ||
Fibronectin interaction with α4β1 integrin prevents apoptosis in B cell chronic lymphocytic leukemia: correlation with Bcl-2 and Bax | Q58498644 | ||
Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia | Q60197192 | ||
Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia | Q60358460 | ||
CD49d in B-cell chronic lymphocytic leukemia: correlated expression with CD38 and prognostic relevance | Q60358511 | ||
Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia | Q60358526 | ||
CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential | Q61640131 | ||
Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status | Q62028005 | ||
Molecular characterization of dipeptidyl peptidase activity in serum | Q62660688 | ||
CD26 (dipeptidyl peptidase IV/DPP IV) as a novel molecular marker for differentiated thyroid carcinoma | Q71820188 | ||
Cross-linking of CD26 by antibody induces tyrosine phosphorylation and activation of mitogen-activated protein kinase | Q73307202 | ||
Aberrant dipeptidyl peptidase IV (DPP IV/CD26) expression in human hepatocellular carcinoma | Q73677307 | ||
P433 | issue | 3 | |
P304 | page(s) | 140-147 | |
P577 | publication date | 2009-09-01 | |
P1433 | published in | Hematological Oncology | Q15762617 |
P1476 | title | CD26 expression in mature B-cell neoplasia: its possible role as a new prognostic marker in B-CLL. | |
P478 | volume | 27 |
Q36979261 | Accelerated progression of chronic lymphocytic leukemia in Eμ-TCL1 mice expressing catalytically inactive RAG1. |
Q24628943 | Automated pattern-guided principal component analysis vs expert-based immunophenotypic classification of B-cell chronic lymphoproliferative disorders: a step forward in the standardization of clinical immunophenotyping |
Q39816788 | CD26 expression on T cell lines increases SDF-1-alpha-mediated invasion |
Q57801281 | CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myeloma |
Q42279712 | CD26: A prognostic marker of other systemic malignancies besides colo-rectal carcinomas |
Q38848633 | CD49d associates with nodal presentation and subsequent development of lymphadenopathy in patients with chronic lymphocytic leukaemia |
Q37510305 | CD9 negatively regulates CD26 expression and inhibits CD26-mediated enhancement of invasive potential of malignant mesothelioma cells |
Q38751579 | Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system |
Q38760903 | DPPIV/CD26: a tumor suppressor or a marker of malignancy? |
Q35653850 | Developing Molecular Signatures for Chronic Lymphocytic Leukemia |
Q52776417 | Development and analytical performance of a new ARCHITECT automated dipeptidyl peptidase-4 immunoassay. |
Q35723683 | Differential Expression and Enzymatic Activity of DPPIV/CD26 Affects Migration Ability of Cervical Carcinoma Cells. |
Q44713190 | Dipeptidyl peptidase IV: serum activity and expression on lymphocytes in different hematological malignancies. |
Q36124370 | Improved ZAP-70 assay using two clones, multiple methods of analysis and clinical correlation |
Q35113393 | Potential of soluble CD26 as a serum marker for colorectal cancer detection. |
Q40539875 | Prognostic relevance of stromal CD26 expression in rectal cancer after chemoradiotherapy |
Q34386621 | Serum activity of DPPIV and its expression on lymphocytes in patients with melanoma and in people with vitiligo |
Q37948956 | Surface profiles for subclassification of chronic lymphocytic leukemia. |
Q52323624 | Targeting the Adenosinergic Axis in Chronic Lymphocytic Leukemia: A Way to Disrupt the Tumor Niche? |
Q37674999 | The dipeptidyl peptidase IV family in cancer and cell biology. |
Search more.